8-KEarnings & ResultsExhibits & Filings

ABBOTT LABORATORIES 8-K Report, Financial Results (Apr 19, 2006)

Filed April 19, 2006For Securities:ABT

Summary

This 8-K filing from Abbott Laboratories, dated April 19, 2006, primarily announces the company's financial results for the first quarter of 2006. The report highlights the use of non-GAAP financial measures by Abbott's management to provide a clearer view of ongoing business performance, excluding certain specified items like merger-related costs, restructuring charges, and litigation expenses. These adjusted figures are presented to offer investors a better understanding of the company's operational performance beyond standard GAAP reporting. While the filing itself does not contain the detailed financial figures, it references a press release (Exhibit 99.1) issued on the same date, which would contain the specific quarterly earnings and key performance indicators. Investors should refer to this press release for the actual financial data and a comprehensive breakdown of the non-GAAP adjustments made by Abbott.

Key Highlights

  • 1Abbott Laboratories announced its first quarter 2006 results of operations.
  • 2The company utilizes non-GAAP financial measures to report earnings, excluding certain specified items.
  • 3These non-GAAP measures are intended to provide investors with a better evaluation of ongoing business performance.
  • 4Exclusions from non-GAAP measures include merger-related costs, purchase accounting adjustments, restructuring and impairment charges, certain litigation charges, and impacts of changes in laws and regulations.
  • 5Abbott's management uses these non-GAAP measures internally for performance monitoring.
  • 6The filing explicitly cautions investors to consider non-GAAP measures in addition to, and not as a substitute for, GAAP measures.
  • 7The detailed financial results are provided in a press release furnished as Exhibit 99.1.

Frequently Asked Questions

The main purpose of this 8-K filing is to announce Abbott Laboratories' financial results for the first quarter of 2006 and to highlight the company's use of non-GAAP financial measures in reporting these results.

Non-GAAP financial measures are financial metrics that exclude certain items from the standard Generally Accepted Accounting Principles (GAAP) reporting. Abbott uses them to present earnings and earnings per share excluding specified items like merger costs, restructuring charges, and litigation expenses, believing these adjusted figures provide a better view of ongoing business performance.

The actual detailed financial results are not included in this 8-K filing itself. They are presented in a press release dated April 19, 2006, which is furnished as Exhibit 99.1 to this report.

No, Abbott cautions investors to consider these non-GAAP financial measures in addition to, and not as a substitute for, financial measures prepared in accordance with GAAP. It's important to look at both standard GAAP reporting and the adjusted non-GAAP figures for a complete understanding.